Merck (MRK) Tops Q2 EPS by 2c; Updates FY16 EPS Outlook

July 29, 2016 6:46 AM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Merck (NYSE: MRK) reported Q2 EPS of $0.93, $0.02 better than the analyst estimate of $0.91. Revenue for the quarter came in at $9.84 billion versus the consensus estimate of $9.78 billion.


Merck sees FY2016 EPS of $3.67-$3.77, versus the consensus of $3.72.

For earnings history and earnings-related data on Merck (MRK) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot Earnings, Hot Guidance

Related Entities